The art of tissue-specific and disease-specific dosing may emerge in the not-too-distant future: Rather than using the current pharmacologic doses of GLP-1s to soak receptors throughout the body, we may learn how to apply much more tailored brush strokes to effectively treat, say, dementia or rheumatoid arthritis
Available under brand names including Wegovy (FDA-approved for weight loss) and Ozempic (FDA-approved for diabetes, not for weight loss), semaglutide mimics the action of naturally occurring GLP-1, a hormone released by the intestine in response to food intake
Consuming electrolyte solutions can assist in balancing electrolytes properly
What Actually Breaks for Patients, Emotionally and Operationally
Anesthesia Concerns Semaglutide and GLP-1 receptor agonists alter gastric emptying and metabolic status that may modify usual anesthesia approaches
Telogen effluvium is typically temporary and tied to stressors such as rapid weight change or illness